Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Curated Information Page
PubMed Id: 10652299 
Klein S, et al. (2000) Biochemical analysis of the arginine methylation of high molecular weight fibroblast growth factor-2. J Biol Chem 275, 3150-7 10652299
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2012,40:D261-70). To learn more about the scope of PhosphoSitePlus®, click here.
Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.
Only sites from this record are displayed on this page. Click on the protein name to open the protein page, and on the RSD number to open the site page. For the complete dataset, click the download button, on the right.
Download Sites

R82-m2 - FGF2 (human)
Orthologous residues
FGF2 (human): R82‑m2, FGF2 (mouse): , FGF2 (rat):

R84-m2 - FGF2 (human)
Orthologous residues
FGF2 (human): R84‑m2, FGF2 (mouse): , FGF2 (rat):

R86-m2 - FGF2 (human)
Orthologous residues
FGF2 (human): R86‑m2, FGF2 (mouse): , FGF2 (rat):

R96-m2 - FGF2 (human)
Orthologous residues
FGF2 (human): R96‑m2, FGF2 (mouse): , FGF2 (rat):

R98-m2 - FGF2 (human)
Orthologous residues
FGF2 (human): R98‑m2, FGF2 (mouse): , FGF2 (rat):

R108-m2 - FGF2 (human)
Orthologous residues
FGF2 (human): R108‑m2, FGF2 (mouse): , FGF2 (rat):

R110-m2 - FGF2 (human)
Orthologous residues
FGF2 (human): R110‑m2, FGF2 (mouse): , FGF2 (rat):

R112-m2 - FGF2 (human)
Orthologous residues
FGF2 (human): R112‑m2, FGF2 (mouse): , FGF2 (rat):

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.